Product Stewardship

We recognize we have a role to play in the drive towards a greener and more sustainable society that goes beyond simply manufacturing greener products. We have a product stewardship approach at the company and site level that considers product safety and sustainability throughout the value chain. This not only supports regulatory compliance but also helps us to develop safer and more sustainable solutions for our customers.

We support the aims of the European Green Deal, the EU Chemical Strategy for Sustainability, the developing US Toxic Substances Control Act legislation and the further development of chemicals management legislation around the world.

Risk assessment and hazard communication

We handle 4,000 substances, including raw materials in our production and R&D samples. Of these, 2,200 are sold and used throughout the world and have gone through a hazard assessment. In 2020, 77% of Nouryon’s net revenue came from products containing substances which are Globally Harmonized System (GHS) category 1 and 2 Health and Environmental Hazards.

Our core competencies are in complex and hazardous chemistries and the handling of highly reactive chemicals. All substances are carefully managed to ensure they are used safely at our production sites and by our customers.

Our company-wide procedure addresses the requirements for hazard information and communication and our processes align with GHS chemical classification and labeling requirements as well as other applicable national and regional regulations. This includes collecting hazard information for the raw materials used in our manufacturing processes and creating up-to-date Material Safety Data Sheets (MSDSs), which comply with legislation in the region where they are used. A hazard assessment must be performed for all new substances manufactured by, or toll manufactured for, Nouryon and for existing substances when new safety information becomes available.


To ensure new substances in our products can be used safely, they undergo a risk assessment. This process includes assessment of potential exposure to workers, consumers, or the environment. Recommendations for measures to manage the risks are then communicated to suppliers and customers throughout the value chain. The methodology for risk assessment varies depending upon the region. For example, in Europe we use REACH chemical safety assessment and communicate the uses through an extended MSDS, in accordance with the REACH regulation.

Learn more about REACH @Nouryon

Genetically modified organisms

We do not manufacture genetically modified organisms (GMOs). We do not sell products that use GMOs to provide any specific functionality, nor do we use GMOs in manufacturing processes to impart any specific variability. Certain raw  materials we use are derived from crops that have been produced from GMOs prior to our use.

Examples include soybean oil and cotton cellulose linters. These materials are used in products that make up roughly 3% of our products by revenue. 

We are continuously monitoring the on-going debate around GMO usage and will act upon any new findings as appropriate.

Managing substances of concern

We proactively monitor new and future substances of concern (SoCs) through our Priority Substance Program to ensure that no new SoCs are introduced in our products. This is a global systematic program that uses REACH methodology for risk assessments and promotes substitution of harmful substances in our raw materials and products with more sustainable alternatives.

The basic process for all Nouryon innovation projects is a stage-gate methodology.

Questions we ask in the process include:

  • Does the product contain any SoCs?
  • Are there any substances which are prohibited, restricted, or under
    review in our products or raw materials?
  • Have all identified substances been evaluated?

In 2020, 9% of our net revenue came from products containing SoCs (>0.1% by weight). These substances are carefully managed to ensure they can be manufactured and used safely. All of these have undergone a risk assessment according to REACH methodology, 50% are on the REACH Annex XIV (Authorization) list, and 38% are on the REACH Annex XVII (Restriction) list.

Developing alternatives through innovation

Related content